Chile: Carlyle Group makes new offer for EMV – Founders ask for vote to be delayed
US-based investors The Carlyle Group have been outed as interested parties in snatching up the assets of healthcare chain Isapre-Masvida, creating a rift within the latter’s board, which was in advanced talks with rival Nexus.
Carlyle Group, which owns local companies Doggis, Juan Maestro and Mamut, has said it will formally communicate their offer to EMV’s directors, seeking to take over Masvida, Isapre and the entirety of their passive and active assets and clinics, with a value estimated at $150 bn pesos (approx. $232.4 million US), to be paid in cash.
The proposal arrives at a tense time for EMV’s board, which is divided over those who have pushed for the Nexus deal and board members from the Concepción region, who have not looked kindly on Nexus’ offer. This partly due to what they consider a low offer of $35 bn ($54 million US) for the Mas Vida affiliates portfolio, as well as for the short timetable and tight deadline given to respond and study the offer.
Full Content: Pulso
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Big Tech Braces for Potential Changes Under a Second Trump Presidency
Nov 6, 2024 by
CPI
Trump’s Potential Shift in US Antitrust Policy Raises Questions for Big Tech and Mergers
Nov 6, 2024 by
CPI
EU Set to Fine Apple in First Major Enforcement of Digital Markets Act
Nov 5, 2024 by
CPI
Six Indicted in Federal Bid-Rigging Schemes Involving Government IT Contracts
Nov 5, 2024 by
CPI
Ireland Secures First €3 Billion Apple Tax Payment, Boosting Exchequer Funds
Nov 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI